leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...219220221222223224225226227228229...235236»
  • ||||||||||  Kinselby (resminostat) / 4SC, Yakult Honsha
    Enrollment change, Combination therapy, Metastases:  SHORE: 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma (clinicaltrials.gov) -  Jan 14, 2014   
    P1/2,  N=17, Active, not recruiting, 
    Active, not recruiting --> Completed N=80 --> 17
  • ||||||||||  5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., gemcitabine / Generic mfg.
    Trial completion, Metastases:  Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer (clinicaltrials.gov) -  Jan 14, 2014   
    P3,  N=107, Completed, 
    N=80 --> 17 Active, not recruiting --> Completed
  • ||||||||||  5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
    Enrollment open, Metastases:  Phase I Trial of Combination of FOLFIRI and SOM 230 (clinicaltrials.gov) -  Jan 6, 2014   
    P1,  N=30, Recruiting, 
    Recruiting --> Active, not recruiting Suspended --> Recruiting
  • ||||||||||  aminopterin / Syntrix
    Trial completion, Grant:  Aminopterin in Treating Patients With Refractory Leukemia (clinicaltrials.gov) -  Jan 1, 2014   
    P2,  N=75, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
    Enrollment closed, Metastases:  APC-S1: Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers (clinicaltrials.gov) -  Dec 25, 2013   
    P2,  N=92, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Erbitux (cetuximab) / Eli Lilly
    Enrollment change, Metastases:  FLOX + Cetuximab (Erbitux (clinicaltrials.gov) -  Dec 17, 2013   
    P2,  N=152, Completed, 
    Completed --> Withdrawn N=86 --> 152